You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR TESLASCAN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TESLASCAN

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00966563 ↗	Mangafodipir as an Adjunct to Percutaneous Coronary Intervention	Completed	Egetis Therapeutics	Phase 2	2009-12-01	The present feasibility study is designed to find out whether pre-treatment with the compound mangafodipir (PP-099) provides an additional reduction in myocardial infarct size in patients treated with primary percutaneous coronary intervention (PCI) during acute myocardial infarction (AMI).
NCT00966563 ↗	Mangafodipir as an Adjunct to Percutaneous Coronary Intervention	Completed	PledPharma AB	Phase 2	2009-12-01	The present feasibility study is designed to find out whether pre-treatment with the compound mangafodipir (PP-099) provides an additional reduction in myocardial infarct size in patients treated with primary percutaneous coronary intervention (PCI) during acute myocardial infarction (AMI).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TESLASCAN

Condition Name

Chart
Table

Condition Name for TESLASCAN
Intervention	Trials
Myocardial Infarction	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TESLASCAN
Intervention	Trials
Myocardial Infarction	1
Infarction	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TESLASCAN

Trials by Country

Map
Table

Trials by Country for TESLASCAN
Location	Trials
Sweden	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TESLASCAN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TESLASCAN
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TESLASCAN
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TESLASCAN

Sponsor Name

Chart
Table

Sponsor Name for TESLASCAN
Sponsor	Trials
Egetis Therapeutics	1
PledPharma AB	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TESLASCAN
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.